googleads

Global Choroidal Neovascularization Market 2016-2020

  • Published: Feb 2016
  • Pages: 60
  • SKU: IRTNTR8546
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version!

Choroidal neovascularization (CNV) market forecast

Choroidal neovascularization is a medical condition that is characterized by the formation of new blood vessels in the choroid layer of the eye. This condition is often associated with myopia, malignant myopic degeneration, or age-related macular degeneration (AMD). The global market for choroidal neovascularization is an emerging market and is characterized by the entry of many new vendors.

Choroidal neovascularization market drivers

A notable factor that will impel the prospects for growth in this market is the recent increase in the prevalence of chronic eye diseases. In industrialized and middle-income countries, the incidence of eye diseases is rising with the rising prevalence of chronic illnesses like diabetes and hypertension. These conditions lead to the development of diabetic retinopathy, macular edema, and AMD.

Table of Content

PART 01: Executive summary

  • Highlights

PART 02: Scope of  the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Key buying criteria

PART 05: Disease overview

  • Introduction
  • Pathophysiology
  • Symptoms
  • Management
  • Epidemiology

PART 06: Product portfolio of approved therapies

PART 07: Pipeline analysis

  • OHR-102
  • RTH258
  • Fovista
  • RG7716
  • PF-04523655
  • NT-503
  • LFG316
  • REGN2176-3
  • Zimura
  • LHA510
  • DE-120

PART 08: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 09: Market segmentation by ROA

  • IV
  • Intravitreal

PART 10: Geographical segmentation

  • Global choroidal neovascularization market by geographical segmentation 2015-2020
  • Choroidal neovascularization market in Americas
  • Choroidal neovascularization market in EMEA
  • Choroidal neovascularization market in APAC

PART 11: Market drivers

  • Growing older population
  • Increased prevalence of chronic diseases
  • High patient and physician satisfaction
  • Increase in diagnosis rate

PART 12: Impact of drivers

PART 13: Market challenges

  • High cost of treatment
  • Limited public awareness
  • Side effects associated with treatment options
  • Availability of alternative therapies

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Strategic alliances and M&A
  • Increased initiatives and programs
  • Use of combination therapies
  • Increase in R&D

PART 16: Vendor landscape

  • Competitive scenario
  • Market analysis 2015
  • F. Hoffmann-La Roche
  • Novartis
  • Regeneron Pharmaceuticals
  • Bayer HealthCare
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations
  • PART 18: Explore Technavio
Safe and Secure SSL Encrypted
Technavio
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

*For Enterprise license, go to checkout page

*Avail subscription at 50% off, with report purchase - limited to a week

  • 2500 USD


[5 reports/month/user]

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

  • 5000 USD

Quick BuyTechnavio
View Free Data Sample
VIEW FREE SAMPLE PDF

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights